The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.
Open accessAbstract
We used radioligand binding techniques and measurement of beta-agonist-mediated positive inotropic responses in isolated cardiac tissue to examine beta-adrenergic-receptor subpopulations in nonfailing and failing human left and right ventricular myocardium. In tissue derived from 48 human hearts the receptor subtypes identified in nonfailing ventricle by radioligand binding were beta 1 (77%) and beta 2 (23%), with no evidence of an "atypical" beta-adrenergic receptor. In failing left ventricle the beta 1:beta 2 ratio was markedly different, i.e., 60:38. This decrease in the beta 1 proportion and increase in the beta 2 proportion in the failing ventricles were due to a 62%, "selective" down-regulation of the beta 1 subpopulation, with little or no change in beta 2 receptors. In muscle bath experiments in isolated trabeculae derived from nonfailing and failing right ventricles, both beta 1- and beta 2-adrenergic receptors were coupled to a positive inotropic response. In nonfailing myocardium, beta 1 responses predominated, as the selective beta 1 agonist denopamine produced a response that was 66% of the total contractile response of isoproterenol. In heart failure the beta 1 component was markedly decreased, while the beta 2 component was not significantly diminished. Moreover, in heart failure the beta 2 component increased in prominence, as the contractile response to the selective beta 2 agonist zinterol increased from a minority (39%) to a majority (60%) of the total response generated by isoproterenol. We conclude that failing human ventricular myocardium contains a relatively high proportion of beta 2 receptors, due to selective down-regulation of beta 1 receptors. As a result, in the failing human heart the beta 2-receptor subpopulation is a relatively important mediator of inotropic support in response to nonselective beta-agonist stimulation and is available for inotropic stimulation by selective beta 2 agonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A simplification of the protein assay method of Lowry et al. which is more generally applicable
Peterson, G. L. (1977) · Analytical Biochemistry · doi:10.1016/0003-2697(77)90043-4 · Cited by 8,524
LIGAND: A versatile computerized approach for characterization of ligand-binding systems
Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,429
Multivariate Statistical Methods
(2008) · Encyclopedia of Public Health · doi:10.1007/978-1-4020-5614-7_2263 · Cited by 5,580
Some statistical methods useful in circulation research.
Wallenstein, S., Zucker, C. L., & Fleiss, J. L. (1980) · Circulation Research · doi:10.1161/01.res.47.1.1 · Cited by 3,886
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111303 · Cited by 3,125
DeLean, A., Munson, P. J., & Rodbard, D. (1978) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1978.235.2.e97 · Cited by 2,374
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
Bristow, M. R., Ginsburg, R., Minobe, W., Cubicciotti, R. S., Sageman, W. S., Lurie, K., Billingham, M. E., Harrison, D. C., & Stinson, E. B. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207223070401 · Cited by 2,270
Self-citationDifferentiation of Receptor Systems activated by Sympathomimetic Amines
LANDS, A. M., ARNOLD, A., MCAULIFF, J. P., LUDUENA, F. P., & BROWN, T. G. (1967) · Nature · doi:10.1038/214597a0 · Cited by 2,065
A generalized multivariate analysis of variance model useful especially for growth curve problems
POTTHOFF, R. F., & ROY, S. N. (1964) · Biometrika · doi:10.1093/biomet/51.3-4.313 · Cited by 1,068
Multivariate Statistical Methods.
Chambers, J. M., & Morrison, D. F. (1967) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2982527 · Cited by 906
Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs
Arch, J. R. S., Ainsworth, A. T., Cawthorne, M. A., Piercy, V., Sennitt, M. V., Thody, V. E., Wilson, C., & Wilson, S. (1984) · Nature · doi:10.1038/309163a0 · Cited by 728
Analysis of Growth and Dose Response Curves
Grizzle, J. E., & Allen, D. M. (1969) · Biometrics · doi:10.2307/2528795 · Cited by 503
The Pharmacology of a β2-Selective Adrenoceptor Antagonist (ICI 118,551)
Bilski, A. J., Halliday, S. E., Fitzgerald, J. D., & Wale, J. L. (1983) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198305000-00013 · Cited by 416
Engel, G., Hoyer, D., Berthold, R., & Wagner, H. (1981) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00501307 · Cited by 390
Mlab — A mathematical modeling tool
Knott, G. D. (1979) · Computer Programs in Biomedicine · doi:10.1016/0010-468x(79)90075-8 · Cited by 380
THE PHARMACOLOGICAL DIFFERENTIATION OF ADRENERGIC RECEPTORS*
Furchgott, R. F. (1967) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1967.tb41229.x · Cited by 376
A note on a manova model applied to problems in growth curve
Khatri, C. G. (1966) · Annals of the Institute of Statistical Mathematics · doi:10.1007/bf02869518 · Cited by 371
Colucci, W. S., Alexander, R. W., Williams, G. H., Rude, R. E., Holman, B. L., Konstam, M. A., Wynne, J., Mudge, G. H., & Braunwald, E. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107233050402 · Cited by 338
MINNEMAN, K. P., HEGSTRAND, L. R., & MOLINOFF, P. B. (1979) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11387-4 · Cited by 252
$beta;-Adrenergic function in heart muscle disease and heart failure
BRISTOW, M. (1985) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(85)90007-0 · Cited by 188
Self-citationThe Adrenergic Nervous System in Heart Failure
Bristow, M. R. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111310 · Cited by 172
Self-citationPharmacology and inotropic potential of forskolin in the human heart.
Bristow, M. R., Ginsburg, R., Strosberg, A. D., Montgomery, W., & Minobe, W. A. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111404 · Cited by 135
Self-citationBrodde, O., Karad, K., Zerkowski, H. R., Rohm, N., & Reidemeister, J. C. (1983) · Circulation Research · doi:10.1161/01.res.53.6.752 · Cited by 122
Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure.
Weber, K. T., Andrews, V., Janicki, J. S., Likoff, M. J., & Reichek, N. (1982) · Circulation · doi:10.1161/01.cir.66.6.1262 · Cited by 77
Hedberg, A., Kempf, F., Josephson, M., & Molinoff, P. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23687-4 · Cited by 70
Kenakin, T., & Beek, D. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32899-5 · Cited by 41
Cited by
Molecular Mechanisms of Myocardial Remodeling
SWYNGHEDAUW, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.215 · Cited by 1,460
β-Adrenergic Receptor Blockade in Chronic Heart Failure
Bristow, M. R. (2000) · Circulation · doi:10.1161/01.cir.101.5.558 · Cited by 1,028
Self-citationNeurohormonal activation in heart failure with reduced ejection fraction
Hartupee, J., & Mann, D. L. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.163 · Cited by 709
Adrenergic Nervous System in Heart Failure: Pathophysiology and Therapy
Lymperopoulos, A., Rengo, G., & Koch, W. J. (2013) · Circulation Research · doi:10.1161/circresaha.113.300308 · Cited by 607
A Gain-of-function Polymorphism in a G-protein Coupling Domain of the Human β1-Adrenergic Receptor
Mason, D. A., Moore, J. D., Green, S. A., & Liggett, S. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12670 · Cited by 583
Metadata
- Authors
- Bristow, M. R., Ginsburg, R., Umans, V, Fowler, M., Minobe, W., Rasmussen, R., Zera, P., Menlove, R., Shah, P., & Jamieson, S.
- Venue
- Circulation Research
- Published
- 1986-09
- Volume
- 59
- Issue
- 3
- Pages
- 297-309
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2097149135
- Cited by
- 1,327
- References
- 26
- FWCI
- 10.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.